Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIVERAL: Raltegravir in HIV Patients With End Stage Liver Disease Before and After Liver Transplant
NCT01022476Phase 2Completed
- Sponsor
- ANRS
- Start
- May 2010
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by ANRS. Primary endpoints: Pharmacokinetic parameters of raltegravir and Pharmacokinetic parameters of immunosuppressive drugs. Started May 2010; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01022476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01022476.